Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
35 hedge funds and large institutions have $44.8M invested in Psychemedics Corporation in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
3% more funds holding
Funds holding: 34 → 35 (+1)
1% less capital invested
Capital invested by funds: $45M → $44.8M (-$225K)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q2 2016 in Review
35 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2016, worth a combined $44.8M — down 0.5% from $45M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PMD positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 12 trimmed.
The largest buyer was Moors & Cabot, adding an estimated $1.26M. The largest seller was Punch & Associates Investment Management, cutting an estimated $730K.
- 35 institutional investors held Psychemedics Corporation (PMD) as of Q2 2016, up from 34 in Q1 2016.
- Funds reported $44.8M of Psychemedics Corporation stock for Q2 2016, down 0.5% quarter-over-quarter.
- 2 funds opened new Psychemedics Corporation positions in Q2 2016 and 1 closed out, a net change of +1 holder.
- The largest Psychemedics Corporation buyer in Q2 2016 was Moors & Cabot, an estimated $1.26M added.
- The largest Psychemedics Corporation seller in Q2 2016 was Punch & Associates Investment Management, an estimated $730K sold.
Based on aggregated 13F filings for Q2 2016.